Concepedia

Allan Powe

AP

Statistics

Publications

5

Citations

721

H-Index

5

Active since

2002

Affiliations

Amicus Therapeutics (United States)(Current)

Allan Powe is an author at Amicus Therapeutics (United States) specializing in biochemistry, molecular biology, and enzymology.

Publications per year

2002–2014

5

Publications

5

Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease

Raquel L. Lieberman, Brandon A. Wustman, Pedro E. Huertas et al. · Nature Chemical Biology · 2006 · 242 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanisms

Richard Steet, Stephen Chung, Brandon A. Wustman et al. · Proceedings of the National Academy of Sciences · 2006 · 217 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of <b>β</b>‐glucosidase

Richie Khanna, Elfrida R. Benjamin, Lee Pellegrino et al. · FEBS Journal · 2010 · 158 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Mutation of Walker‐A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide‐binding domains

Allan Powe, Layla Al‐Nakkash, Min Li et al. · The Journal of Physiology · 2002 · 65 citations · Full text

Natural Sciences, Biochemistry, Biophysics +17

The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease

Richie Khanna, Allan Powe, Yi Lun et al. · PLoS ONE · 2014 · 39 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

1–5 of 5